Diammonium glycyrrhizinate

甘草酸二铵

Report date: 2023/03/21 20:00:39
NME

Base Information

Drug NameDiammonium glycyrrhizinate
Drug Alias Name18b-Glycyrrhizic acid diammonium salt
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors
TargetsCorticosteroid 11-beta-dehydrogenase isozyme 1
Therapy Area/IndicationsHepatitis
Global Approved IndicationsHepatitis
Approved Indications in ChinaHepatitis
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHepatitis
Inactive IndicationsN/A

Other Information

ATC CodeA05A
Related LinksKEGG